SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-005860
Filing Date
2014-08-14
Accepted
2014-08-14 14:47:06
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0614_dandritbio.htm 10-Q 566093
2 CERTIFICATION f10q0614ex31i_dandritbio.htm EX-31.1 10392
3 CERTIFICATION f10q0614ex31ii_dandritbio.htm EX-31.2 7874
4 CERTIFICATION f10q0614ex32i_dandritbio.htm EX-32.1 2966
5 CERTIFICATION f10q0614ex32ii_dandritbio.htm EX-32.2 2931
  Complete submission text file 0001213900-14-005860.txt   3990107

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmhs-20140630.xml EX-101.INS 483691
7 XBRL SCHEMA FILE pmhs-20140630.xsd EX-101.SCH 40620
8 XBRL CALCULATION FILE pmhs-20140630_cal.xml EX-101.CAL 47437
9 XBRL DEFINITION FILE pmhs-20140630_def.xml EX-101.DEF 81120
10 XBRL LABEL FILE pmhs-20140630_lab.xml EX-101.LAB 341174
11 XBRL PRESENTATION FILE pmhs-20140630_pre.xml EX-101.PRE 220751
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54478 | Film No.: 141041890
SIC: 2834 Pharmaceutical Preparations